Abstract: Objective Glycine acts as a co-agonist for the activation of N-methyl-D-aspartate receptors (NMDARs) by binding to glycine sites, thus potentiating glutamate-elicited responses and inhibiting NMDAR desensitization in a dosedependent manner. The present study aimed to characterize the glycine-dependent inactivation of NMDARs and to explore its pathophysiological significance. Methods Primary hippocampal cell cultures from embryonic days 17-18 rats were treated with NMDA or NMDA plus glycine. Patch-clamp recording and intracellular Ca 2+ imaging were performed to test the effects of glycine on NMDA-activated currents and increase of intracellular free Ca 2+ respectively. Immunofluorescence staining was conducted to examine NR1 internalization. Cell damage was tested with MTT method and lactate dehydrogenase leakage.
Introduction
The N-methyl-D-aspartate receptor (NMDAR), one of the ionotropic glutamate receptors, plays a key role in physiological and pathophysiological processes such as the development and modification of synaptic plasticity, long-term potentiation and long-term depression [1, 2] , as well as in such disorders as ischemia, epilepsy, trauma, and dementia [1, 3] . NMDARs are abundantly distributed throughout the central nervous system. Currently, they are considered to be unique among ligand-gated ion channels in their requirement for a necessary co-agonist, glycine, in Yun-Feng Zhang, et al. Novel glycine-dependent inactivation of NMDA receptors in cultured hippocampal neurons 551 addition to the synaptic neurotransmitter glutamate [4, 5] . Two independent binding sites have been identified for glycine and glutamate, located on the NR1 and NR2 subunits, respectively [6, 7] . It has been found that, upon binding to the glycine site, glycine potentiates the glutamate-elicited response and inhibits the desensitization of NMDARs [4, 8, 9] .
To study the regulatory role of glycine in detail, NMDAmediated currents and Ca 2+ influx were assayed in primary hippocampal neurons from juvenile rats. We were surprised to find a novel inhibitory influence of glycine on NMDARs when NMDA was administered at a high concentration. The present study was designed to characterize this glycine-dependent inactivation of NMDARs and to explore its pathophysiological significance.
Materials and methods

Animals and chemicals Sprague-Dawley rats were obtained from the Experimental Animal Center of Nantong
University, Nantong, China. All procedures were in accordance with the Institutional Guidelines of Nantong University, which comply with international rules and policies, and approved by the Animal Care and Use Committee.
Common inorganic salts (NaCl, KCl, CaCl 2 , MgCl 2 and NaOH) were from Sinopharm Chemical Reagent Co. Ltd.
(Shanghai, China); dimethylformamide, paraformaldehyde, sucrose, and glucose from Xilong Chemical Co. Ltd. Louis, MO).
Cell culture and transfection Primary hippocampal
cell cultures were prepared as described [10] . The degree of desensitization of NMDA currents was determined according to the following equation: desensitization score = 1 -I ss /I p , where I p is the peak current, and I ss is the steady-state current of I NMDA (Fig. 1) . The degree of desensitization was positively related to the calculated desensitization score. Fig. 2A) . Meanwhile, the desensitization score of I NMDA decreased with increasing glycine concentration (Fig. 2C) . However, when the NMDA concentration was raised to 300 μmol/L, we stumbled across the inhibition of the peak current by glycine (Fig. 2B) , while the desensitization score still decreased with increasing glycine concentration (Fig. 2D) . This is inconsistent with the previous view that glycine acts as a co-agonist for NMDAR activation by binding to the glycine site, potentiates the glutamate-elicited response, and decreases the NMDAR desensitization in a dose-dependent manner. Besides, we (Fig. 3A, C) , but decreased Ca 2+ influx when 300 μmol/L NMDA was applied (Fig. 3B,   D) . We also found that the peak [Ca 2+ ] i induced by NMDA increased in a dose-dependent manner without the addition of glycine (Fig. 3E, F μmol/L and 1 mmol/L (Fig. 3E, F ).
NMDAR internalization does not occur on the cell membrane, regardless of being primed by glycine binding
It is possible that the observed inhibitory effect was due with non-pretreated neurons (Fig. 4A , B) . ] i evoked by 1 mmol/L NMDA (Fig. 5A, B) .
Influence of glycine on viability of neurons exposed
to NMDA To investigate the potential pathophysiological significance of the inhibitory influence of glycine on
NMDARs at higher concentrations of NMDA, we measured the viability of neurons and LDH leakage from hippocampal neurons exposed to combinations of different concentrations of NMDA and glycine. We found that glycine dose-dependently increased the LDH leakage ( Fig.   6A ) and reduced the viability (Fig. 6B) when NMDA was applied at 30 μmol/L. Therefore, we postulate that glycine can facilitate NMDA-induced neurotoxicity. In contrast, when NMDA was used at 300 μmol/L, glycine reversed the NMDA-induced LDH leakage dose-dependently, and the viability was significantly elevated by glycine at 10 μmol/L (Fig. 6D , P <0.05). These results indicate that glycine can protect hippocampal neurons against the excitotoxicity induced by higher concentrations of NMDA.
Discussion
Glycine is well known as a co-agonist in the activation of NMDARs. However, in the present study, we discovered that glycine not only played a co-agonist role but also exerted an inhibitory influence on NMDARs if the concentration of NMDA was raised to 300 μmol/L in cultured rat hippocampal neurons. Glycine dose-dependently inhibited the peak current and Ca 2+ influx elicited by 300 μmol/L NMDA. To our knowledge, this inhibitory effect of glycine on NMDARs has not been reported previously, and its significance as well as the specific mechanism involved has not been identified.
Many mechanisms are known to diminish the response of NMDARs, including surface membrane receptor internalization, Ca
2+
-dependent inactivation, glycine-dependent desensitization, and glycine-independent desensitization [11] [12] [13] . Therefore, we designed a series of experiments to investigate the problem. Because some previous studies have raised the possibility that NMDARs undergo regulated transport to and from the cell surface [14, 15] , we measured the expression of surface NMDARs while applying a On the other hand, Ca 2+ -dependent inactivation is a reversible decrease in peak current, which can be induced by a rise in extracellular Ca 2+ concentration, without agonist activation of the receptor itself [16, 17] . Desensitization is a decrease in the current response induced by the persistent presence of a glutamate site agonist [8] . Thus, it is intriguing to consider that the inhibitory phenomenon we revealed in the present study, which is in contrast to the glycinedependent desensitization, may be a glycine-dependent inactivation of NMDARs.
Glycine-dependent desensitization is a well-known phenomenon. While binding to the glycine site of NMDARs, glycine potentiates glutamate-elicited responses and inhibits the desensitization of NMDARs [4, 8, 9] . We also found glycinedependent desensitization. When NMDA was applied at 30 μmol/L, glycine elevated the peak current and Ca 2+ influx and decreased the desensitization of I NMDA . These results are consistent with previous reports [4, 8, 9] . Glycine, a coagonist for activation of NMDARs, is also an inhibitory neurotransmitter in the central nervous system.
Next, we sought to exclude the possibility of the involvement of glycine receptor activation by using strychnine, an antagonist of this receptor. We found that strych- including polyamines, zinc, pH, redox agents and intracellular signaling molecules [3, 12] , is rather complicated. The results of the present study suggest that this complexity is further increased by a novel glycine-dependent inactivation process.
In addition, we showed that continuing exposure to NMDA induced LDH release and decreased viability in evoked depolarization in the rat striatum [18] . However, the investigators in that study did not exclude the possibility of the involvement of strychnine-sensitive glycine receptors, as glycine at the concentrations used is known to activate these receptors. Therefore, the novel inhibitory influence of glycine on NMDARs reported here has potential physiological and pathophysiological significance for protecting neurons from excessive activation of NMDARs when glutamate is released above physiological levels due to excessive glutamatergic activity.
In conclusion, our results suggest that a novel glycinedependent inactivation occurs while NMDARs are activated by 300 μmol/L NMDA. This inhibitory effect occurs via binding to the glycine site of NMDARs but is not due to activation of the strychnine-sensitive glycine-receptorgated chloride channel. The inhibitory influence of glycine on NMDARs adds a new insight to our knowledge about the complexity of, and feedback loops involved in, synaptic transmission.
